Validation of the important role and prognostic value of KIF14 in triple-negative breast cancer
KIF14 promotes TNBC progression and serves as a potential diagnostic and prognostic biomarker for TNBC.
Authors
- Jingjing Yuan (ORCID: https://orcid.org/0000-0002-3144-6123)
- Yiran Qiu (ORCID: https://orcid.org/0000-0001-8669-1209)
- Yaxuan Liu (ORCID: https://orcid.org/0000-0001-5848-419X)
- Hongliang Chen (ORCID: https://orcid.org/0000-0002-2563-2018)
- Meilin Zhang (ORCID: https://orcid.org/0000-0001-8991-9133)
Institutions
- Obstetrics and Gynecology Hospital of Fudan University (CN)
Publication Details
- Journal
- Cancer Biology & Therapy
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1080/15384047.2025.2600705
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00